Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 28, 2020

Total Value ($000): $81,136 (100.0% shares, 0.0% debt)

Holdings (11)

CYTK Cytokinetics Incorporated 31.6%

Value ($000) $25,670 Shares 2,177,292 Est. Cost $8.13 Unrealized +57.0%

— Myokardia, Inc. 17.8%

Value ($000) $14,411 Shares 307,400 Est. Cost $47.61 Unrealized —

FULC Fulcrum Therapeutics, Inc. 14.7%

Value ($000) $11,924 Shares 998,655 Est. Cost $11.06 Unrealized +44.6%

INSM Insmed Incorporated 13.4%

Value ($000) $10,874 Shares 678,322 Est. Cost $26.85 Unrealized -11.7%

— Biohaven Pharmaceutical Holding Company Ltd. 6.6%

Value ($000) $5,321 Shares 156,355 Est. Cost $34.03 Unrealized —

VYGR Voyager Therapeutics, Inc. 5.8%

Value ($000) $4,728 Shares 516,751 Est. Cost $21.95 Unrealized —

— Aerie Pharmaceuticals, Inc. 3.8%

Value ($000) $3,074 Shares 227,717 Est. Cost $24.60 Unrealized —

— bluebird bio, Inc. 2.8%

Value ($000) $2,298 Shares 50,000 Est. Cost $45.96 Unrealized —

— Kiniksa Pharmaceuticals, Ltd. 1.2%

Value ($000) $1,006 Shares 65,000 Est. Cost $15.48 Unrealized —

KURA Kura Oncology, Inc. 1.1%

Value ($000) $925 Shares 93,000 Est. Cost $13.91 Unrealized -17.7%

QURE uniQure N.V. 1.1%

Value ($000) $905 Shares 19,082 Est. Cost $57.46 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CYTK	Cytokinetics Incorporated	2,177,292	$25,670	31.6%	$8.13	+57.0%	COM	23282W605
—	Myokardia, Inc.	307,400	$14,411	17.8%	$47.61	—	COM	62857M105
FULC	Fulcrum Therapeutics, Inc.	998,655	$11,924	14.7%	$11.06	+44.6%	COM	359616109
INSM	Insmed Incorporated	678,322	$10,874	13.4%	$26.85	-11.7%	COM	457669307
—	Biohaven Pharmaceutical Holding Company Ltd.	156,355	$5,321	6.6%	$34.03	—	COM	G11196105
VYGR	Voyager Therapeutics, Inc.	516,751	$4,728	5.8%	$21.95	—	COM	92915B106
—	Aerie Pharmaceuticals, Inc.	227,717	$3,074	3.8%	$24.60	—	COM	00771V108
—	bluebird bio, Inc.	50,000	$2,298	2.8%	$45.96	—	COM	09609G100
—	Kiniksa Pharmaceuticals, Ltd.	65,000	$1,006	1.2%	$15.48	—	COM	G5269C101
KURA	Kura Oncology, Inc.	93,000	$925	1.1%	$13.91	-17.7%	COM	50127T109
QURE	uniQure N.V.	19,082	$905	1.1%	$57.46	0.0%	SHS	N90064101